Development & Preliminary Validation of a Community Health Education Program
NCT ID: NCT07301398
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
92 participants
OBSERVATIONAL
2025-12-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ILD patients often experience labored and rapid breathing, which limits their ability to perform daily activities. Low levels of physical function and vitality, coupled with severe dyspnea and fatigue, lead to a poor quality of life for these patients. Currently, clinical treatments can only control disease progression to a certain extent. Enhancing ILD patients' knowledge of their condition, encouraging active participation of patients and their families in nursing care, and improving patients' ability to monitor and manage their own health can effectively reduce the risk of infections, ensure the clinical efficacy of implemented treatment plans, and further alleviate patients' clinical symptoms.
With societal progress and advances in medical technology, telemedicine has gradually been applied in clinical practice. Telemedicine interventions have proven beneficial for the home-based management and control of chronic diseases such as hypertension and diabetes. Therefore, integrating telemedicine with existing medical and nursing approaches for the home-based health guidance of ILD patients constitutes an innovative research with significant scientific value.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Intervention Measures for the Control Group: Patients in the control group received interventions through routine health education, telephone follow-up, and questionnaire surveys during follow-up visits. Health education covered disease-related knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up once a month via telephone or home visit, and questionnaire data were collected during their follow-up consultations.
No interventions assigned to this group
Experimental Group
Intervention Measures for the Experimental Group: On the basis of routine health education, the experimental group additionally received guidance on the use of the mini-program. Patients were instructed to proficiently use the mini-program's functions, including accessing health education information, interacting with medical staff, and understanding the precautions for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to master the mini-program to irregularly push health education-related knowledge to patients, and medical staff were instructed on the effective collection of questionnaire data and data statistics.
The use and guidance of the mini-program
Interventions were conducted through routine health education, telephone follow-ups, and questionnaire surveys during reconsultations. Health education covered disease knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up by telephone or home visit once a month, and questionnaire data were collected during their reconsultations. The use of a mini-program was added with corresponding guidance: patients were instructed to proficiently use the mini-program's functions for accessing health education information, interacting with medical staff, and noting key points for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to skillfully use the mini-program to push health education-related knowledge to patients at irregular intervals, and medical staff were trained on the effective collection of questionnaire data and data statistics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The use and guidance of the mini-program
Interventions were conducted through routine health education, telephone follow-ups, and questionnaire surveys during reconsultations. Health education covered disease knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up by telephone or home visit once a month, and questionnaire data were collected during their reconsultations. The use of a mini-program was added with corresponding guidance: patients were instructed to proficiently use the mini-program's functions for accessing health education information, interacting with medical staff, and noting key points for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to skillfully use the mini-program to push health education-related knowledge to patients at irregular intervals, and medical staff were trained on the effective collection of questionnaire data and data statistics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-2025-126
Identifier Type: -
Identifier Source: org_study_id